iconstar paper   Hepatitis C Articles (HCV)  
Back grey arrow rt.gif
New NYS HCV Guidelines
  Download the PDF here Strategic Plan
Download the PDF here Provider Direcotry
The goal of treatment in patients with chronic HCV infection is to attain a virologic cure, as evidenced by an SVR, in order to reduce all-cause mortality and liver-related complications, including end-stage liver disease, hepatocellular carcinoma (HCC), and the morbidity and mortality associated with the extrahepatic manifestation of chronic HCV infection. With the significant advances in treatment, all patients with chronic HCV infection, regardless of fibrosis stage, are considered candidates for antiviral therapy [2-4] .
Purpose of This Guideline
This guideline on treatment of chronic hepatitis C virus (HCV) infection was developed by the New York State (NYS) Department of Health (DOH) AIDS Institute (AI) to guide primary care providers and other practitioners in New York State in treating patients with chronic HCV infection. The guideline aims to achieve the following goals:
⋅Increase the number of NYS residents with chronic HCV infection treated with the new direct-acting antiviral (DAA) therapies that cure chronic HCV infection.
⋅Increase compliance with the 2014 NYS public health law that requires HCV antibody screening be offered to every individual born between 1945 and 1965 who receives healthcare services from a physician, physician assistant, or nurse practitioner in a primary care or inpatient hospital setting.
⋅Reduce the growing burden of morbidity and mortality associated with chronic HCV infection.
⋅Integrate current evidence-based clinical recommendations into the HCV-related implementation strategies of the Ending the Epidemic (ETE) initiative, which seeks to end the AIDS epidemic in NYS by the end of 2020.
The NYSDOH AI is publishing these guidelines at a critical time: 1) new treatments are available that can cure chronic HCV infection; 2) the burden of HCV disease is increasing in NYS [1]; and 3) primary care providers and other clinical care practitioners in NYS are playing an essential role in screening for and diagnosing chronic HCV infection and in providing state-of-the-art therapy for their patients.
NYSDOH HCV Rapid Testing Program.....This program provides free HCV Rapid Test Kits and Controls to agencies that serve populations at highest risk for HCV......https://www.health.ny.gov/publications/1805/index.htm
Viral Hepatitis Strategic Plan 2016 - 2020.....https://www.health.ny.gov/diseases/communicable/hepatitis/strategic/index.htm


New York State HCV Provider Directory.....https://www.health.ny.gov/diseases/communicable/hepatitis/hepatitis_c/docs/provider_directory.pdf http://www.hivguidelines.org/hcv-infection/treatment-with-daa/#tab_5


Hepatitis C Virus Infection Guideline Committee, July 2017

  iconpaperstack View Older Articles   Back to Top   www.natap.org